Price History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price above all key MAs — strong uptrend
Price Action
Support & Resistance Levels
Volume Analysis
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹875.6 Cr | ₹1,030.8 Cr | ₹1,099.2 Cr | ₹1,121 Cr |
| Net Profit | ₹101.4 Cr | ₹159 Cr | ₹158.4 Cr | ₹95 Cr |
| EPS | — | ₹5.92 | ₹5.89 | ₹3.54 |
| Operating Profit | ₹196.5 Cr | ₹267 Cr | ₹266.7 Cr | ₹202.5 Cr |
Peer Comparison
HospitalPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| APOLLOHOSP | Apollo Hospitals Enterprise Limited | ₹8,498.00 | +0.06% |
| MAXHEALTH | Max Healthcare Institute Limited | ₹1,012.45 | +0.28% |
| FORTIS | Fortis Healthcare Limited | ₹990.35 | +0.14% |
| ASTERDM | Aster DM Healthcare Limited | ₹814.95 | +0.15% |
| NH | Narayana Hrudayalaya Ltd. | ₹1,893.90 | +1.90% |
| KIMS | Krishna Institute of Medical Sciences Limited | ₹785.10 | +2.57% |
| AGARWALEYE | Dr. Agarwal's Health Care Limited | ₹439.75 | +0.08% |
| RAINBOW | Rainbow Childrens Medicare Limited | ₹1,365.00 | +1.87% |
| PARKHOSPS | Park Medi World Limited | ₹274.60 | +0.49% |
| HCG | Healthcare Global Enterprises Limited | ₹630.50 | +0.17% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 22 Aug 2025 | Dividend - Re 0.50 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for MEDANTA
View All
FSSAI asks food businesses to stop using metallic pins, wires in packaging
The FSSAI has issued a strict directive to all food business operators. They must immediately cease using metallic pins and wires for packaging food items and parcels. This measure is crucial for public health and food safety. Non-compliance will lead to penal action under the FSS Act, 2006. The regulator highlighted the serious hazard of pins being consumed, causing injury.
Alembic Pharmaceuticals receives USFDA approval for Tretinoin Cream USP, 0.05%
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tretinoin Cream USP, 0.05%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Retin-A Cream, 0.05%, of Bausch Health US, LLC. Tretinoin cream is indicated for topical application in the treatment of acne vulgaris.
Concord Biotech completes ANVISA inspection at Limbasi API facility
Concord Biotech announced the successful completion of an inspection conducted by Brazil's National Health Surveillance Agency (ANVISA) at its active pharmaceutical ingredient (API) manufacturing facility in Limbasi.